Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Detecting changes in patient treatment satisfaction with medicines: the SATMED-Q.

Rejas J, Ruiz M, Pardo A, Soto J.

Value Health. 2013 Jan-Feb;16(1):88-96. doi: 10.1016/j.jval.2012.08.2224.

2.

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q).

Rejas J, Ruiz MA, Pardo A, Soto J.

BMC Med Res Methodol. 2011 Oct 20;11:142. doi: 10.1186/1471-2288-11-142.

3.

Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).

Ruiz MA, Pardo A, Rejas J, Soto J, Villasante F, Aranguren JL.

Value Health. 2008 Sep-Oct;11(5):913-26. doi: 10.1111/j.1524-4733.2008.00323.x. Epub 2008 May 20.

4.

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.

Steigerwald I, Müller M, Davies A, Samper D, Sabatowski R, Baron R, Rozenberg S, Szczepanska-Szerej A, Gatti A, Kress HG.

Curr Med Res Opin. 2012 Jun;28(6):911-36. doi: 10.1185/03007995.2012.679254. Epub 2012 May 9.

PMID:
22443293
5.

Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?

Sevilla C, Jiménez Caballero PE, Alfonso V, González-Adalid M.

Dement Geriatr Cogn Disord. 2009;28(3):196-205. doi: 10.1159/000236015. Epub 2009 Sep 9.

PMID:
19738386
6.

Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.

Arnold LM, Palmer RH, Gendreau RM, Chen W.

Psychosomatics. 2012 Jul-Aug;53(4):371-9. doi: 10.1016/j.psym.2012.02.005. Epub 2012 Jun 6.

PMID:
22677218
7.

Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).

Margolis MK, Fox KM, Cerulli A, Ariely R, Kahler KH, Coyne KS.

Neurourol Urodyn. 2009;28(5):416-22. doi: 10.1002/nau.20672.

PMID:
19030182
8.

Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain.

Rejas J, Ribera MV, Ruiz M, Masrramón X.

Eur J Pain. 2007 Apr;11(3):329-40. Epub 2006 Jun 12.

PMID:
16765622
9.

Predictors of patient satisfaction with pain management and improvement 3 months after burn injury.

Andrews RM, Browne AL, Wood F, Schug SA.

J Burn Care Res. 2012 May-Jun;33(3):442-52. doi: 10.1097/BCR.0b013e31823359ee.

PMID:
22210057
10.

Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting.

Blanco Tarrio E, Gálvez Mateos R, Zamorano Bayarri E, López Gómez V, Pérez Páramo M.

Clin Drug Investig. 2013 Sep;33(9):633-45. doi: 10.1007/s40261-013-0116-7. Erratum in: Clin Drug Investig. 2014 May;34(5):371.

11.

[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].

Zanello A, Weber Rouget B, Gex-Fabry M, Maercker A, Guimon J.

Encephale. 2006 Jan-Feb;32(1 Pt 1):45-59. French.

PMID:
16633290
12.

Patients' satisfaction after a comprehensive assessment for complex chronic facial pain at a specialised unit: results from a prospective audit.

Napeñas JJ, Nussbaum ML, Eghtessad M, Zakrzewska JM.

Br Dent J. 2011 Dec 16;211(12):E24. doi: 10.1038/sj.bdj.2011.1054.

PMID:
22193507
13.

Development of the asthma treatment satisfaction measure.

Martin ML, Patrick DL, Bushnell DM, Meltzer EO, Gutierrez B, Parasuraman B.

Curr Med Res Opin. 2009 Oct;25(10):2495-506. doi: 10.1185/03007990903158430.

PMID:
19689222
14.

Assessing satisfaction with pain medication in primary care patients: development and psychometric validation of a new measure.

Baró E, Casado A, García-Cases C, Clerch L, Ribas S.

Clin Ther. 2004 Jul;26(7):1124-36.

PMID:
15336478
15.

Development and psychometric testing of a short version of the Barriers Questionnaire-Taiwan form for cancer patients.

Chou PL, Rau KM, Lin CC.

Int J Nurs Stud. 2011 Sep;48(9):1071-9. doi: 10.1016/j.ijnurstu.2011.02.006. Epub 2011 Mar 10.

PMID:
21396643
16.
17.
18.

Comparison of short- and long-term outcomes for aggressive spine rehabilitation delivered two versus three times per week.

Rainville J, Jouve CA, Hartigan C, Martinez E, Hipona M.

Spine J. 2002 Nov-Dec;2(6):402-7.

PMID:
14589260
19.

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.

Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y.

Arthritis Rheum. 2010 Sep;62(9):2745-56. doi: 10.1002/art.27559.

20.

The impact of personal functional goal achievement on patient satisfaction with progress one year following completion of a functional restoration program for chronic disabling spinal disorders.

Hazard RG, Spratt KF, McDonough CM, Carayannopoulos AG, Olson CM, Reeves V, Sperry ML, Ossen ES.

Spine (Phila Pa 1976). 2009 Dec 1;34(25):2797-802. doi: 10.1097/BRS.0b013e3181a9e640.

Supplemental Content

Support Center